Catalyst PharmaceuticalsCPRX

那斯達克 · USD
19.86
+0.23
(+1.15%)
收盤 08/09 03:59 (UTC+8)
盤後 
19.89 
+0.08 
(+0.40%)
08/09 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.61
  • 0.85
  • 1.00
  • 1.03
  • 1.11
  • 0.99
  • 1.23
  • 1.29
  • 1.42
  • 1.41
icon
  • 6.14
  • 40.50
  • 16.65
  • 3.12
  • 7.67
  • -10.91
  • 24.57
  • 4.88
  • 10.20
  • -0.28
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
營業收入淨額
141,421
141,820
128,695
122,710
98,509
110,568
102,688
99,582
85,366
60,757
營業成本
17,91121,64319,27715,40512,52015,80914,16712,0459,94611,195
營業毛利
123,510
120,177
109,418
107,305
85,989
94,759
88,521
87,537
75,420
49,562
營業費用
---53,059-53,067125,70940,83839,81118,761
研發費用
3,8873,7983,2842,9852,5811,97283,6623,9543,5624,093
推銷及管理費用
46,91144,19245,88040,73046,93842,03633,56028,39629,71815,186
非經常性項目費用
----------
其他營業費用
9,3459,3449,3459,3449,3449,0598,4878,4886,531-518
營業利益
63,367
62,843
50,909
54,246
27,126
41,692
-37,188
46,699
35,609
30,801
其他收入及費用
7,91911,3386,2961,5421,9635,015-8331,8131,7042,207
利息費用
----------
稅前純益
71,286
74,181
57,205
55,788
29,089
46,707
-38,021
48,512
37,313
33,008
所得稅
14,54918,24513,32114,9945,81411,863-7,25710,7507,7457,537
稅後純益
56,737
55,936
43,884
40,794
23,275
34,844
-30,764
37,762
29,568
25,471
基本每股稅後盈餘(元)
0.470.470.370.350.20--0.290.360.280.24
稀釋每股稅後盈餘(元)
0.450.440.350.330.190.31-0.270.330.260.23
基本平均股數(千股)
121472.00119892.00118931.00118180.00116806.00-106568.00106258.00105561.00104583.00
稀釋平均股數(千股)
126957.00126280.00125407.00124655.00123403.00-106568.00113673.00113986.00113531.00
還原基本每股稅後盈餘(元)
0.470.470.370.350.20--0.290.360.280.24
還原稀釋每股稅後盈餘(元)
0.450.440.350.330.190.31-0.270.330.260.23
還原基本平均股數(千股)
121,472119,892118,931118,180116,806-106,568106,258105,561104,583
還原稀釋平均股數(千股)
126,957126,280125,407124,655123,403-106,568113,673113,986113,531
EBITDA(千元)
80,68683,60065,57365,35738,67256,024-28,30757,08243,91333,606

大家都在看

HOT